Aarti Drugs Ltd. - Research Center
524348 AARTIDRUGS Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sales | 2,251.17 | 1,914.89 | 1,634.92 | 1,454.25 | 1,140.46 |
| Operating profit | 318.18 | 401.28 | 244.40 | 199.29 | 181.85 |
| Interest | 20.06 | 22.61 | 32.20 | 37.56 | 33.01 |
| Gross profit | 302.89 | 385.09 | 213.26 | 168.01 | 150.01 |
| EPS (Rs) | 21.06 | 27.65 | 58.23 | 37.01 | 31.13 |
Annual
results in details
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Other income | 4.77 | 6.42 | 1.06 | 6.28 | 1.17 |
| Stock adjustment | -77.94 | -9.08 | -53.94 | 19.05 | -55.60 |
| Raw material | 1,524.56 | 1,127.79 | 1,078.80 | 930.14 | 745.65 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 69.32 | 69.29 | 60.10 | 53.14 | 50.49 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 417.05 | 325.61 | 305.56 | 252.63 | 218.07 |
| Provisions made | - | - | - | - | - |
| Depreciation | 47.39 | 47.60 | 46.67 | 40.39 | 37.80 |
| Taxation | 60.50 | 80.00 | 39.30 | 40.36 | 38.80 |
| Net profit / loss | 195.00 | 257.71 | 135.67 | 87.26 | 73.41 |
| Extra ordinary item | - | 0.22 | 8.38 | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 92.60 | 93.20 | 23.30 | 23.58 | 23.58 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 14.13 | 20.96 | 14.95 | 13.70 | 15.95 |
| GPM (%) | 13.43 | 20.04 | 13.04 | 11.50 | 13.14 |
| NPM (%) | 8.64 | 13.41 | 8.29 | 5.97 | 6.43 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis